• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Heliyon . Immunogenic epitope prediction to create a universal influenza vaccine

tetano

Editor, Senior Moderator
Heliyon


. 2022 Apr 30;8(5):e09364.
doi: 10.1016/j.heliyon.2022.e09364. eCollection 2022 May.
Immunogenic epitope prediction to create a universal influenza vaccine


R R Mintaev[SUP] 1 2 [/SUP], D V Glazkova[SUP] 1 [/SUP], E V Bogoslovskaya[SUP] 1 [/SUP], G A Shipulin[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Influenza virus is one of the most rapidly evolving human pathogens and causes significant morbidity and mortality worldwide. This feature enables the virus to avoid natural or vaccine-induced immunity. For this reason, there is an intensive search for new approaches to create a universal influenza vaccine. Here, we propose pipelines based on modern prediction algorithms that allowed us to select 10 B-cell epitopes, 10 CD8+ T-cell epitopes and 6 CD4+ T-cell epitopes from influenza viruses that were characterized by high conservation and antigenicity. These epitopes could be used to create universal vaccines against influenza viruses. In addition, the scripts used in these pipelines are universal and can be used to select epitopes from other pathogens.

Keywords: Computational approaches; Influenza; T- and B-cell epitopes; Universal vaccine.
 
Back
Top Bottom